TFS CAPITAL LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 128 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$257,000
-62.6%
2,403
-81.4%
0.04%
-43.9%
Q4 2014$688,000
-81.2%
12,930
-76.2%
0.07%
-72.7%
Q1 2014$3,658,000
+68.8%
54,375
+8.6%
0.24%
+144.4%
Q3 2013$2,167,000
+138.4%
50,062
+106.0%
0.10%
+160.5%
Q2 2013$909,00024,3040.04%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders